Studies have shown that TRPM2-AS can promote the malignant phenotype of ovarian cancer (OC) [7], retinoblastoma (RB) [8], gastric cancer (GC) [9], esophageal cancer (EC) [10], and other tumor cells and then promote the development of tumors. This evidence concerns the gene TRPM2 and retinoblastoma.